Long-Term Treatment of Postmenopausal Osteoporosis.
Brown JP.
Endocrinol Metab (Seoul). 2021 Jun;36(3):544-552. doi: 10.3803/EnM.2021.301. Epub 2021 Jun 22.
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society.
[No authors listed]
Menopause. 2021 Sep 1;28(9):973-997. doi: 10.1097/GME.0000000000001831.
Postmenopausal Osteoporosis: A Review of Latest Guidelines.
Subarajan P, Arceo-Mendoza RM, Camacho PM.
Endocrinol Metab Clin North Am. 2024 Dec;53(4):497-512. doi: 10.1016/j.ecl.2024.08.008. Epub 2024 Oct 5.
Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2.
ACOG Committee on Clinical Practice Guidelines–Gynecology.
Obstet Gynecol. 2022 Apr 1;139(4):698-717. doi: 10.1097/AOG.0000000000004730.
The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil.
Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM.
Clin Interv Aging. 2015 Mar 20;10:583-91. doi: 10.2147/CIA.S54614. eCollection 2015.
Use of bone turnover markers in postmenopausal osteoporosis.
Eastell R, Szulc P.
Lancet Diabetes Endocrinol. 2017 Nov;5(11):908-923. doi: 10.1016/S2213-8587(17)30184-5. Epub 2017 Jul 7.
Bone Health and Osteoporosis Prevention and Treatment.
Muñoz M, Robinson K, Shibli-Rahhal A.
Clin Obstet Gynecol. 2020 Dec;63(4):770-787. doi: 10.1097/GRF.0000000000000572.
Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis.
Yao Y, Cai X, Chen Y, Zhang M, Zheng C.
Med Res Rev. 2025 Mar;45(2):561-575. doi: 10.1002/med.22081. Epub 2024 Sep 5.
The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis.
Li J, Chen X, Lu L, Yu X.
Cytokine Growth Factor Rev. 2020 Apr;52:88-98. doi: 10.1016/j.cytogfr.2020.02.003. Epub 2020 Feb 10.
Pathophysiology of osteoporosis: new mechanistic insights.
Armas LA, Recker RR.
Endocrinol Metab Clin North Am. 2012 Sep;41(3):475-86. doi: 10.1016/j.ecl.2012.04.006. Epub 2012 Jun 9.
